| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Gastrointestinal Imaging |
1 From the Department of Radiology, Duke University Medical Center, Box 3808, Erwin Rd, Durham, NC 27710 (D.H.S., J.S.K., E.K.P., D.M.D., R.C.N.) and Windsong Radiology, Buffalo, NY (A.M.F.). Received April 15, 1999; revision requested June 2; revision received June 30; accepted August 11. Address reprint requests to D.H.S. (e-mail: sheaf001@mc.duke.edu).
PURPOSE: To evaluate the efficacy of hepatic enhancement characteristics for identification of patients with breast cancer who are at risk for future hepatic metastases.
MATERIALS AND METHODS: Triple-phase helical computed tomography (CT) was performed in 60 patients with known breast cancer without visible hepatic metastases. Peak hepatic attenuation and enhancement, and attenuation and enhancement at 25 and 30 seconds were obtained. Ratios of hepatic attenuation or enhancement at 25 and 30 seconds to peak hepatic attenuation or enhancement were calculated. A Wilcoxon rank sum test was used to compare patients with and those without subsequent hepatic metastases.
RESULTS: During a mean 18-month follow-up, 18 patients (30%) developed hepatic metastases. Decreases in peak hepatic attenuation and enhancement and increases in hepatic attenuation and enhancement ratios at 25 and 30 seconds were seen in patients who developed metastases compared with those who did not (P < .05). When corrected for chemotherapy interval, these differences were not statistically significant. Using a threshold value of 0.40 or more for the enhancement ratio at 30 seconds resulted in sensitivity of 28%, specificity of 92%, and accuracy of 55%.
CONCLUSION: Patients with breast cancer who develop subsequent hepatic metastases have higher relative hepatic arterial perfusion during triple-phase CT; however, after correction for chemotherapy interval, this difference was not statistically significant. Threshold values cannot be used reliably to identify patients who will develop metastases.
Index terms: Breast neoplasms, metastases, 00.79 • Computed tomography (CT), helical, 761.12114, 761.12115, 761.12119 • Liver, blood supply, 761.91 • Liver, CT, 761.12114, 761.12115, 761.12119 • Liver neoplasms, secondary, 761.332
This article has been cited by other articles:
|
|
 |
|
  T. S. Koh, C. H. Thng, P. S. Lee, S. Hartono, H. Rumpel, B. C. Goh, and S. Bisdas Hepatic Metastases: In Vivo Assessment of Perfusion Parameters at Dynamic Contrast-enhanced MR Imaging with Dual-Input Two-Compartment Tracer Kinetics Model Radiology, October 1, 2008; 249(1): 307 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Nakashige, J Horiguchi, A Tamura, T Asahara, F Shimamoto, and K Ito Quantitative measurement of hepatic portal perfusion by multidetector row CT with compensation for respiratory misregistration Br. J. Radiol., September 1, 2004; 77(921): 728 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Kruskal, P. Thomas, R. A. Kane, and S. N. Goldberg Hepatic Perfusion Changes in Mice Livers with Developing Colorectal Cancer Metastases Radiology, May 1, 2004; 231(2): 482 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Braga, R. C. Semelka, R. Pietrobon, D. Martin, N. de Barros, and U. Guller Does Hypervascularity of Liver Metastases as Detected on MRI Predict Disease Progression in Breast Cancer Patients? Am. J. Roentgenol., May 1, 2004; 182(5): 1207 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K A Miles Perfusion CT for the assessment of tumour vascularity: which protocol? Br. J. Radiol., December 1, 2003; 76(suppl_1): S36 - S42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K A Miles and M R Griffiths Perfusion CT: a worthwhile enhancement? Br. J. Radiol., April 1, 2003; 76(904): 220 - 231. [Full Text] [PDF]
|
|
|
|
|
|
M A Fuentes, C J Keith, M Griffiths, G Durbridge, and K A Miles Hepatic haemodynamics: interrelationships between contrast enhancement and perfusion on CT and Doppler perfusion indices Br. J. Radiol., January 1, 2002; 75(889): 17 - 23. [Abstract] [Full Text] [PDF]
|
|
